de Groot V - Search Results

1

Reliability, construct and concurrent validity of a smartphone-based cognition test in multiple sclerosis.

Lam KH, van Oirschot P, den Teuling B, Hulst HE, de Jong BA, Uitdehaag B, de Groot V, Killestein J. Lam KH, et al. Among authors: de groot v, de jong ba. Mult Scler. 2022 Feb;28(2):300-308. doi: 10.1177/13524585211018103. Epub 2021 May 26. Mult Scler. 2022. PMID: 34037472 Free PMC article.

2

Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis.

Lam KH, Meijer KA, Loonstra FC, Coerver E, Twose J, Redeman E, Moraal B, Barkhof F, de Groot V, Uitdehaag B, Killestein J. Lam KH, et al. Among authors: de groot v. Mult Scler. 2021 Aug;27(9):1421-1431. doi: 10.1177/1352458520968797. Epub 2020 Nov 5. Mult Scler. 2021. PMID: 33150823 Free PMC article.

3

Multiple sclerosis functional composite: impact of reference population and interpretation of changes.

Uitdehaag BM, Adèr HJ, Roosma TJ, de Groot V, Kalkers NF, Polman CH. Uitdehaag BM, et al. Among authors: de groot v. Mult Scler. 2002 Oct;8(5):366-71. doi: 10.1191/1352458502ms835oa. Mult Scler. 2002. PMID: 12356201

4

Neuroprotective effects of exercise in people with progressive multiple sclerosis (Exercise PRO-MS): study protocol of a phase II trial.

Gravesteijn AS, Beckerman H, de Jong BA, Hulst HE, de Groot V. Gravesteijn AS, et al. Among authors: de groot v, de jong ba. BMC Neurol. 2020 May 11;20(1):177. doi: 10.1186/s12883-020-01765-6. BMC Neurol. 2020. PMID: 32393193 Free PMC article.

5

MS functional composite: relation to disease phenotype and disability strata.

Kalkers NF, de Groot V, Lazeron RH, Killestein J, Adèr HJ, Barkhof F, Lankhorst GJ, Polman CH. Kalkers NF, et al. Among authors: de groot v. Neurology. 2000 Mar 28;54(6):1233-9. doi: 10.1212/wnl.54.6.1233. Neurology. 2000. PMID: 10746590

6

Concurrent validity of the MS Functional Composite using MRI as a biological disease marker.

Kalkers NF, Bergers L, de Groot V, Lazeron RH, van Walderveen MA, Uitdehaag BM, Polman CH, Barkhof F. Kalkers NF, et al. Among authors: de groot v. Neurology. 2001 Jan 23;56(2):215-9. doi: 10.1212/wnl.56.2.215. Neurology. 2001. PMID: 11160958

7

The usefulness of evaluative outcome measures in patients with multiple sclerosis.

de Groot V, Beckerman H, Uitdehaag BM, de Vet HC, Lankhorst GJ, Polman CH, Bouter LM. de Groot V, et al. Among authors: de vet hc. Brain. 2006 Oct;129(Pt 10):2648-59. doi: 10.1093/brain/awl223. Epub 2006 Sep 6. Brain. 2006. PMID: 16956906 Free article.

8

Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters.

Minneboo A, Jasperse B, Barkhof F, Uitdehaag BM, Knol DL, de Groot V, Polman CH, Castelijns JA. Minneboo A, et al. Among authors: de groot v. J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):917-23. doi: 10.1136/jnnp.2007.124123. Epub 2007 Dec 12. J Neurol Neurosurg Psychiatry. 2008. PMID: 18077480 Free article.

9

The initial course of daily functioning in multiple sclerosis: a three-year follow-up study.

de Groot V, Beckerman H, Lankhorst GJ, Polman CH, Bouter LM. de Groot V, et al. Mult Scler. 2005 Dec;11(6):713-8. doi: 10.1191/1352458505ms1238oa. Mult Scler. 2005. PMID: 16320733

10

Community walking can be assessed using a 10-metre timed walk test.

Kempen JC, de Groot V, Knol DL, Polman CH, Lankhorst GJ, Beckerman H. Kempen JC, et al. Among authors: de groot v. Mult Scler. 2011 Aug;17(8):980-90. doi: 10.1177/1352458511403641. Epub 2011 May 26. Mult Scler. 2011. PMID: 21622593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters